P2Y12 Platelet Inhibitor [EPC]

119949 reported adverse events

Drugs of this class: TICAGRELOR CANGRELOR CLOPIDOGREL TICAGRELORE

These side effects are most commonly reported by patients taking drugs of the P2Y12 Platelet Inhibitor [EPC] class:

# Side effect Count
0 DYSPNOEA 8548
1 FATIGUE 5578
2 MYOCARDIAL INFARCTION 5488
3 DIZZINESS 4857
4 OFF LABEL USE 4440
5 DEATH 4305
6 DRUG INEFFECTIVE 4252
7 DIARRHOEA 4240
8 DRUG INTERACTION 4170
9 NAUSEA 4157
See all common reactions for P2Y12 Platelet Inhibitor [EPC]

Drugs of the P2Y12 Platelet Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR STENT THROMBOSIS 1236 0.6068
1 THROMBOSIS IN DEVICE 630 0.1920
2 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1272 0.1437
3 CORONARY ARTERY STENOSIS 483 0.0959
4 ANGINA UNSTABLE 504 0.0775
5 CORONARY ARTERY OCCLUSION 1038 0.0756
6 ACUTE MYOCARDIAL INFARCTION 2114 0.0716
7 NEPHROGENIC ANAEMIA 331 0.0714
8 ACUTE CORONARY SYNDROME 545 0.0657
9 MELAENA 1431 0.0650
See all enriched reactions for P2Y12 Platelet Inhibitor [EPC]